-
1
-
-
0032840918
-
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
-
DOI 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
-
Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12-19. (Pubitemid 29406813)
-
(1999)
Journal of Pathology
, vol.189
, Issue.1
, pp. 12-19
-
-
Walboomers, J.M.M.1
Jacobs, M.V.2
Manos, M.M.3
Bosch, F.X.4
Kummer, J.A.5
Shah, K.V.6
Snijders, P.J.F.7
Peto, J.8
Meijer, C.J.L.M.9
Munoz, N.10
-
2
-
-
34548497655
-
Human papillomavirus and cervical cancer
-
DOI 10.1016/S0140-6736(07)61416-0, PII S0140673607614160
-
Schiffman M, Castle PE, Jeronimo J, et al. Human papillomavirus and cervical cancer. Lancet. 2007;370:890-907. (Pubitemid 47371147)
-
(2007)
Lancet
, vol.370
, Issue.9590
, pp. 890-907
-
-
Schiffman, M.1
Castle, P.E.2
Jeronimo, J.3
Rodriguez, A.C.4
Wacholder, S.5
-
3
-
-
34648836898
-
2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests
-
DOI 10.1016/j.ajog.2007.07.047, PII S0002937807009301
-
Wright TC Jr, Massad LS, Dunton CJ, et al. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol. 2007;197:346-355. (Pubitemid 47464164)
-
(2007)
American Journal of Obstetrics and Gynecology
, vol.197
, Issue.4
, pp. 346-355
-
-
Wright Jr., T.C.1
Massad, L.S.2
Dunton, C.J.3
Spitzer, M.4
Wilkinson, E.J.5
Solomon, D.6
-
4
-
-
77953705396
-
Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: What screening intervals are physicians recommending?
-
Saraiya M, Berkowitz Z, Yabroff KR, et al. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending? Arch Intern Med. 2010;170:977-985.
-
(2010)
Arch Intern Med
, vol.170
, pp. 977-985
-
-
Saraiya, M.1
Berkowitz, Z.2
Yabroff, K.R.3
-
5
-
-
34548161126
-
Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP)
-
DOI 10.1002/cncr.22875
-
Saraiya M, Irwin KL, Carlin L, et al. Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). Cancer. 2007;110:1024-1032. (Pubitemid 47312868)
-
(2007)
Cancer
, vol.110
, Issue.5
, pp. 1024-1032
-
-
Saraiya, M.1
Irwin, K.L.2
Carlin, L.3
Chen, X.4
Jain, N.5
Benard, V.6
Montano, D.E.7
-
6
-
-
0142062150
-
Chapter 1: Human papillomavirus and cervical cancer: Burden and assessment of causality
-
Bosch FX, De Sanjose S. Chapter 1: Human papillomavirus and cervical cancer: burden and assessment of causality. J Natl Cancer Inst Monogr. 2003:3-13.
-
(2003)
J Natl Cancer Inst Monogr
, pp. 3-13
-
-
Bosch, F.X.1
De Sanjose, S.2
-
7
-
-
34250736244
-
Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: A meta-analysis
-
DOI 10.1016/S1473-3099(07)70158-5, PII S1473309907701585
-
De Sanjose S, Diaz M, Castellsague X, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007;7:453-459. (Pubitemid 46962343)
-
(2007)
Lancet Infectious Diseases
, vol.7
, Issue.7
, pp. 453-459
-
-
De Sanjose, S.1
Diaz, M.2
Castellsague, X.3
Clifford, G.4
Bruni, L.5
Munoz, N.6
Bosch, F.X.7
-
9
-
-
79954434168
-
High-risk human papillomavirus testing in women with ASC-US cytology: Results from the ATHENA HPV study
-
Stoler MH, Wright TC Jr, Sharma A, et al. High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study. Am J Clin Pathol. 2011;135:468-475.
-
(2011)
Am J Clin Pathol
, vol.135
, pp. 468-475
-
-
Stoler, M.H.1
Wright Jr., T.C.2
Sharma, A.3
-
11
-
-
0037165740
-
The 2001 Bethesda System: Terminology for reporting results of cervical cytology
-
Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287:2114-2119. (Pubitemid 34437346)
-
(2002)
Journal of the American Medical Association
, vol.287
, Issue.16
, pp. 2114-2119
-
-
Solomon, D.1
Davey, D.2
Kurman, R.3
Moriarty, A.4
O'Connor, D.5
Prey, M.6
Raab, S.7
Sherman, M.8
Wilbur, D.9
Wright Jr., T.10
Young, N.11
-
13
-
-
80053473617
-
-
Pleasanton, CA: Roche Molecular Systems
-
cobas HPV Test [package insert]. Pleasanton, CA: Roche Molecular Systems; 2009.
-
(2009)
Cobas HPV Test [Package Insert]
-
-
-
15
-
-
26944460457
-
The probability for a Pap test to be abnormal is directly proportional to HPV viral load: Results from a Swiss study comparing HPV testing and liquid-based cytology to detect cervical cancer precursors in 13 842 women
-
DOI 10.1038/sj.bjc.6602728, PII 6602728
-
Bigras G, De Marval F. The probability for a Pap test to be abnormal is directly proportional to HPV viral load: results from a Swiss study comparing HPV testing and liquid-based cytology to detect cervical cancer precursors in 13,842 women. Br J Cancer. 2005;93:575-581. (Pubitemid 43080002)
-
(2005)
British Journal of Cancer
, vol.93
, Issue.5
, pp. 575-581
-
-
Bigras, G.1
De Marval, F.2
-
16
-
-
33746349573
-
Overview of the European and North American studies on HPV testing in primary cervical cancer screening
-
DOI 10.1002/ijc.21955
-
Cuzick J, Clavel C, Petry KU, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer. 2006;119:1095-1101. (Pubitemid 44116919)
-
(2006)
International Journal of Cancer
, vol.119
, Issue.5
, pp. 1095-1101
-
-
Cuzick, J.1
Clavel, C.2
Petry, K.-U.3
Meijer, C.J.L.M.4
Hoyer, H.5
Ratnam, S.6
Szarewski, A.7
Birembaut, P.8
Kulasingam, S.9
Sasieni, P.10
Iftner, T.11
-
17
-
-
33745267064
-
Human papillomavirus testing and liquid-based cytology: Results at recruitment from the new technologies for cervical cancer randomized controlled trial
-
DOI 10.1093/jnci/djj209
-
Ronco G, Segnan N, Giorgi-Rossi P, et al. Human papillomavirus testing and liquid-based cytology: results at recruitment from the New Technologies for Cervical Cancer randomized controlled trial. J Natl Cancer Inst. 2006;98:765-774. (Pubitemid 43983300)
-
(2006)
Journal of the National Cancer Institute
, vol.98
, Issue.11
, pp. 765-774
-
-
Ronco, G.1
Segnan, N.2
Giorgi-Rossi, P.3
Zappa, M.4
Casadei, G.P.5
Carozzi, F.6
Palma, P.D.7
Del, M.A.8
Folicaldi, S.9
Gillio-Tos, A.10
Nardo, G.11
Naldoni, C.12
Schincaglia, P.13
Zorzi, M.14
Confortini, M.15
Cuzick, J.16
Rizzolo, R.17
Mari, D.18
De Marco, L.19
Ghiringhello, B.20
Parisio, F.21
Volante, R.22
Berardengo, E.23
Andrion, A.24
Coverlizza, S.25
Taraglio, S.26
Accinellli, M.G.27
Polla, E.28
Pojer, A.29
Girlando, S.30
Aldovini, D.31
Vettorazzi, M.32
Minucci, D.33
Matteucci, M.34
Onnis, L.35
Insacco, E.36
Lestani, M.37
Vignato, A.38
Manfredi, M.39
Pierotti, P.40
Collina, G.41
Serafini, M.42
Sintoni, C.43
Aldi, M.44
Bondi, A.45
Galanti, G.46
Iossa, A.47
Ciatto, S.48
Cariaggi, M.P.49
Cecchini, S.50
Sani, C.51
Taddie, G.L.52
Brezzi, S.53
Raggi, P.54
Gomes, E.55
Pellegrini, A.56
Schiboni, M.L.57
more..
-
18
-
-
55549122325
-
Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: Joint European cohort study
-
doi:10.1136/bmj.a1754
-
Dillner J, Rebolj M, Birembaut P, et al. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ. 2008;337:a1754. doi:10.1136/bmj.a1754.
-
(2008)
BMJ
, vol.337
-
-
Dillner, J.1
Rebolj, M.2
Birembaut, P.3
-
19
-
-
79952993791
-
A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: Extended follow up in the ARTISTIC trial
-
published online ahead of print February 18, doi:10.1016/j.ejca.2011.01. 008
-
Kitchener HC, Gilham C, Sargent A, et al. A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: extended follow up in the ARTISTIC trial [published online ahead of print February 18, 2011]. Eur J Cancer. doi:10.1016/j.ejca.2011.01.008.
-
(2011)
Eur J Cancer
-
-
Kitchener, H.C.1
Gilham, C.2
Sargent, A.3
-
20
-
-
77957835319
-
Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: Role of persistence
-
Kjaer SK, Frederiksen K, Munk C, et al. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer Inst. 2010;102:1478-1488.
-
(2010)
J Natl Cancer Inst
, vol.102
, pp. 1478-1488
-
-
Kjaer, S.K.1
Frederiksen, K.2
Munk, C.3
-
21
-
-
33748142054
-
Chapter 5: Updating the natural history of HPV and anogenital cancer
-
Moscicki AM, Schiffman M, Kjaer S, et al. Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine. 2006;24(suppl 3):S3/42-S3/51.
-
(2006)
Vaccine
, vol.24
, Issue.SUPPL. 3
-
-
Moscicki, A.M.1
Schiffman, M.2
Kjaer, S.3
-
22
-
-
85058205581
-
The ATHENA human papillomavirus study: Design, methods, and baseline results
-
In press
-
Wright TC Jr, Stoler MH, Behrens CM, et al. The ATHENA human papillomavirus study: design, methods, and baseline results. Am J Obstet Gynecol. In press.
-
Am J Obstet Gynecol
-
-
Wright Jr., T.C.1
Stoler, M.H.2
Behrens, C.M.3
-
23
-
-
23244438005
-
The elevated 10-Year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice
-
DOI 10.1093/jnci/dji187
-
Khan MJ, Castle PE, Lorincz AT, et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst. 2005;97:1072-1079. (Pubitemid 41417924)
-
(2005)
Journal of the National Cancer Institute
, vol.97
, Issue.14
, pp. 1072-1079
-
-
Khan, M.J.1
Castle, P.E.2
Lorincz, A.T.3
Wacholder, S.4
Sherman, M.S.5
Scott, D.R.6
Rush, B.R.7
Glass, A.G.8
Schiffman, M.9
-
24
-
-
0033948721
-
Frequency of cervical smear abnormalities within 3 years of normal cytology
-
DOI 10.1016/S0029-7844(00)00882-6, PII S0029784400008826
-
Sawaya GF, Kerlikowske K, Lee NC, et al. Frequency of cervical smear abnormalities within 3 years of normal cytology. Obstet Gynecol. 2000;96:219-223. (Pubitemid 30447342)
-
(2000)
Obstetrics and Gynecology
, vol.96
, Issue.2
, pp. 219-223
-
-
Sawaya, G.F.1
Kerlikowske, K.2
Lee, N.C.3
Gildengorin, G.4
Washington, A.E.5
-
25
-
-
0037048697
-
Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: Comparison of sensitivity, specificity, and frequency of referral
-
Kulasingam SL, Hughes JP, Kiviat NB, et al. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA. 2002;288:1749-1757.
-
(2002)
JAMA
, vol.288
, pp. 1749-1757
-
-
Kulasingam, S.L.1
Hughes, J.P.2
Kiviat, N.B.3
-
26
-
-
35348967810
-
Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer
-
DOI 10.1056/NEJMoa071430
-
Mayrand MH, Duarte-Franco E, Rodrigues I, et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med. 2007;357:1579-1588. (Pubitemid 47598400)
-
(2007)
New England Journal of Medicine
, vol.357
, Issue.16
, pp. 1579-1588
-
-
Mayrand, M.-H.1
Duarte-Franco, E.2
Rodrigues, I.3
Walter, S.D.4
Hanley, J.5
Ferenczy, A.6
Ratnam, S.7
Coutlee, F.8
Franco, E.L.9
-
27
-
-
0035970728
-
Estimating prevalence when the true disease status is incompletely ascertained
-
DOI 10.1002/sim.907
-
Sasieni P. Estimating prevalence when the true disease status is incompletely ascertained. Stat Med. 2001;20:935-949. (Pubitemid 32249091)
-
(2001)
Statistics in Medicine
, vol.20
, Issue.6
, pp. 935-949
-
-
Sasieni, P.1
-
28
-
-
1442305204
-
Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening
-
Wright TC Jr, Schiffman M, Solomon D, et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol. 2004;103:304-309.
-
(2004)
Obstet Gynecol
, vol.103
, pp. 304-309
-
-
Wright Jr., T.C.1
Schiffman, M.2
Solomon, D.3
-
29
-
-
34848877480
-
Risk assessment to guide the prevention of cervical cancer
-
doi:10.1016/j.ajog.2007.07.049
-
Castle PE, Sideri M, Jeronimo J, et al. Risk assessment to guide the prevention of cervical cancer. Am J Obstet Gynecol. 2007;197:356.e1-356.e6. doi:10.1016/j.ajog.2007.07.049.
-
(2007)
Am J Obstet Gynecol
, vol.197
-
-
Castle, P.E.1
Sideri, M.2
Jeronimo, J.3
|